This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2009 Sep;5(7):949-52.

doi: 10.2217/fon.09.83.

Studying Rac1-induced tumorigenesis suggests antioxidants may help prevent and treat Kaposi's sarcoma

Ryan J Sullivan¹, Liron Pantanowitz, Bruce J Dezube

Affiliations

PMID: 19792964
DOI: 10.2217/fon.09.83

Comment

Studying Rac1-induced tumorigenesis suggests antioxidants may help prevent and treat Kaposi's sarcoma

Ryan J Sullivan et al. Future Oncol. 2009 Sep.

. 2009 Sep;5(7):949-52.

doi: 10.2217/fon.09.83.

Authors

Ryan J Sullivan¹, Liron Pantanowitz, Bruce J Dezube

Affiliation

¹ Beth Israel Deaconess Medical Center, Harvard Medical School, Division of Hematology/Oncology, Boston, MA 02215, USA.

PMID: 19792964
DOI: 10.2217/fon.09.83

No abstract available

PubMed Disclaimer

Comment on

Antitumorigenesis of antioxidants in a transgenic Rac1 model of Kaposi's sarcoma.
Ma Q, Cavallin LE, Yan B, Zhu S, Duran EM, Wang H, Hale LP, Dong C, Cesarman E, Mesri EA, Goldschmidt-Clermont PJ. Ma Q, et al. Proc Natl Acad Sci U S A. 2009 May 26;106(21):8683-8. doi: 10.1073/pnas.0812688106. Epub 2009 May 8. Proc Natl Acad Sci U S A. 2009. PMID: 19429708 Free PMC article.

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Research Materials
- NCI CPTC Antibody Characterization Program